BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 21484568)

  • 1. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
    Di Marzo V; Piscitelli F; Mechoulam R
    Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids and the control of energy balance.
    Matias I; Di Marzo V
    Trends Endocrinol Metab; 2007; 18(1):27-37. PubMed ID: 17141520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation.
    Di Marzo V; Ligresti A; Cristino L
    Int J Obes (Lond); 2009 Jun; 33 Suppl 2():S18-24. PubMed ID: 19528974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
    Bellocchio L; Mancini G; Vicennati V; Pasquali R; Pagotto U
    Curr Opin Pharmacol; 2006 Dec; 6(6):586-91. PubMed ID: 17027338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.
    Matias I; Di Marzo V
    J Endocrinol Invest; 2006; 29(3 Suppl):15-26. PubMed ID: 16751706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A role for the endocannabinoid system in obesity].
    Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
    Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids: some like it fat (and sweet too).
    Matias I; Cristino L; Di Marzo V
    J Neuroendocrinol; 2008 May; 20 Suppl 1():100-9. PubMed ID: 18426508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the endocannabinoid system in the regulation of energy expenditure.
    Cavuoto P; Wittert GA
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):79-86. PubMed ID: 19285262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
    Kunos G; Osei-Hyiaman D
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1101-4. PubMed ID: 18292184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system and the treatment of obesity.
    Pagotto U; Vicennati V; Pasquali R
    Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
    Kunos G
    Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
    Bifulco M; Laezza C; Gazzerro P; Pentimalli F
    Oncol Rep; 2007 Apr; 17(4):813-6. PubMed ID: 17342320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
    Izzo AA; Borrelli F; Capasso R; Di Marzo V; Mechoulam R
    Trends Pharmacol Sci; 2009 Oct; 30(10):515-27. PubMed ID: 19729208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid-CB(1) receptor system in pre- and postnatal life.
    Fride E
    Eur J Pharmacol; 2004 Oct; 500(1-3):289-97. PubMed ID: 15464041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
    Müller-Vahl KR; Emrich HM
    Expert Rev Neurother; 2008 Jul; 8(7):1037-48. PubMed ID: 18590475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid system in food intake and metabolic regulation.
    Jesudason D; Wittert G
    Curr Opin Lipidol; 2008 Aug; 19(4):344-8. PubMed ID: 18607180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite.
    Cooper SJ
    Eur J Pharmacol; 2004 Oct; 500(1-3):37-49. PubMed ID: 15464019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.